TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

MOONLAKE IMMUNOTHERAPEUTICS (NASDAQ: MLTX) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds MoonLake Immunotherapeutics Investors of Upcoming Deadline

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Bernstein Liebhard Llp
MOONLAKE IMMUNOTHERAPEUTICS (NASDAQ: MLTX) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds MoonLake Immunotherapeutics Investors of Upcoming Deadline

A securities fraud class action lawsuit has been filed against MoonLake Immunotherapeutics, alleging misrepresentations about their drug candidate sonelokimab between March 10, 2024, and September 29, 2025.

Insights
XOM   neutral

Mentioned as a peer company in the Houston energy sector


MLTX   negative

The lawsuit alleges the company made misrepresentations about their drug candidate, suggesting potential fraudulent or misleading communications with investors